Related Experiment Videos
The role of Na+/H+ exchange in ischemia-reperfusion
H M Piper1, C Balser, Y V Ladilov
1Physiologisches Institut, Justus-Liebig-Universität, Giessen, FRG.
Insights
Na+/H+ exchanger inhibitors protect heart muscle during ischemia and reperfusion. Pre-ischemic administration is more effective, potentially by reducing sodium and calcium influx, and prolonging acidosis to prevent hypercontracture.
Area of Science:
- Cardiovascular Physiology
- Cellular Acid-Base Balance
Background:
- During ischemia, cardiomyocyte cytosol acidifies, with pH recovery upon reperfusion.
- The Na+/H+ exchanger is a key regulator of intracellular pH (pH(i)).
Purpose of the Study:
- To investigate the protective mechanisms of Na+/H+ exchanger inhibition in ischemic-reperfused myocardium.
- To understand the differential effects of inhibitor administration timing (pre-ischemia vs. reperfusion).
Main Methods:
- The abstract does not specify methods, but implies studies on Na+/H+ exchanger inhibition in cardiac ischemia-reperfusion models.
- Focus on analyzing the impact of inhibitor timing on myocardial protection.
Main Results:
- Na+/H+ exchanger inhibitors show greater protection when given before and during ischemia compared to reperfusion alone.
- Pre-ischemic administration may reduce Na+ and subsequent Ca2+ influx.
- Inhibition during reperfusion prolongs intracellular acidosis, potentially preventing hypercontracture.
Conclusions:
- Na+/H+ exchanger inhibition offers protection against ischemia-reperfusion injury in cardiomyocytes.
- The precise mechanisms underlying this protection, especially regarding timing, require further elucidation.
Abstract:
In ischemia the cytosol of cardiomyocytes acidifies; this is reversed upon reperfusion. One of the major pH(i)-regulating transport systems involved is the Na+/H+ exchanger. Inhibitors of the Na+/H+ exchanger have been found to more effectively protect ischemic-reperfused myocardium when administered before and during ischemia than during reperfusion alone. It has been hypothesized that the protection provided by pre-ischemic administration is due to a reduction in Na+ and secondary Ca2+ influx. Under reperfusion conditions Na+/H/ exchange inhibition also seems protective since it prolongs intracellular acidosis which can prevent hypercontracture. In detail, however, the mechanisms by which Na+/H+ exchange inhibition provides protection in ischemic-reperfused myocardium are still not fully identified.